23 related articles for article (PubMed ID: 38757695)
1. Semiparametric regression analysis of interval-censored competing risks data.
Mao L; Lin DY; Zeng D
Biometrics; 2017 Sep; 73(3):857-865. PubMed ID: 28211951
[TBL] [Abstract][Full Text] [Related]
2. Estimated quadratic inference function for correlated failure time data.
Yan F; Liu Y; Cai J; Zhou H
Biometrics; 2023 Jun; 79(2):1145-1158. PubMed ID: 35146750
[TBL] [Abstract][Full Text] [Related]
3. SEMIPARAMETRIC TRANSFORMATION MODELS WITH MULTILEVEL RANDOM EFFECTS FOR CORRELATED DISEASE ONSET IN FAMILIES.
Liang B; Wang Y; Zeng D
Stat Sin; 2019; 29(4):1851-1871. PubMed ID: 31579362
[TBL] [Abstract][Full Text] [Related]
4. Semiparametric Regression Pursuit.
Huang J; Wei F; Ma S
Stat Sin; 2012 Oct; 22(4):1403-1426. PubMed ID: 23559831
[TBL] [Abstract][Full Text] [Related]
5. Making Sense of Censored Covariates: Statistical Methods for Studies of Huntington's Disease.
Lotspeich SC; Ashner MC; Vazquez JE; Richardson BD; Grosser KF; Bodek BE; Garcia TP
Annu Rev Stat Appl; 2024 Apr; 11():255-277. PubMed ID: 38962579
[TBL] [Abstract][Full Text] [Related]
6. Inference for set-based effects in genetic association studies with interval-censored outcomes.
Sun R; Zhu L; Li Y; Yasui Y; Robison L
Biometrics; 2023 Jun; 79(2):1573-1585. PubMed ID: 35165890
[TBL] [Abstract][Full Text] [Related]
7. ROBUST MIXED EFFECTS MODEL FOR CLUSTERED FAILURE TIME DATA: APPLICATION TO HUNTINGTON'S DISEASE EVENT MEASURES.
Garcia TP; Ma Y; Marder K; Wang Y
Ann Appl Stat; 2017; 11(2):1085-1116. PubMed ID: 29399240
[TBL] [Abstract][Full Text] [Related]
8. A constrained single-index regression for estimating interactions between a treatment and covariates.
Park H; Petkova E; Tarpey T; Ogden RT
Biometrics; 2021 Jun; 77(2):506-518. PubMed ID: 32573759
[TBL] [Abstract][Full Text] [Related]
9. Full random effects models (FREM): A practical usage guide.
Jonsson EN; Nyberg J
CPT Pharmacometrics Syst Pharmacol; 2024 Jun; ():. PubMed ID: 38937897
[TBL] [Abstract][Full Text] [Related]
10. A semi-parametric weighted likelihood approach for regression analysis of bivariate interval-censored outcomes from case-cohort studies.
Lou Y; Wang P; Sun J
Lifetime Data Anal; 2023 Jul; 29(3):628-653. PubMed ID: 36862277
[TBL] [Abstract][Full Text] [Related]
11. Semiparametric regression analysis of clustered interval-censored failure time data with a cured subgroup.
Yang D; Du M; Sun J
Stat Med; 2021 Dec; 40(30):6918-6930. PubMed ID: 34634837
[TBL] [Abstract][Full Text] [Related]
12. A new and unified method for regression analysis of interval-censored failure time data under semiparametric transformation models with missing covariates.
Lou Y; Ma Y; Du M
Stat Med; 2024 May; 43(11):2062-2082. PubMed ID: 38757695
[TBL] [Abstract][Full Text] [Related]
13. A semiparametric imputation approach for regression with censored covariate with application to an AMD progression study.
Ding Y; Kong S; Kang S; Chen W
Stat Med; 2018 Oct; 37(23):3293-3308. PubMed ID: 29845616
[TBL] [Abstract][Full Text] [Related]
14. Semiparametric regression analysis of partly interval-censored failure time data with application to an AIDS clinical trial.
Zhou Q; Sun Y; Gilbert PB
Stat Med; 2021 Sep; 40(20):4376-4394. PubMed ID: 34080723
[TBL] [Abstract][Full Text] [Related]
15. Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data.
Zhou Q; Cai J; Zhou H
Lifetime Data Anal; 2020 Jan; 26(1):85-108. PubMed ID: 30617753
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
